Skip to content

When did humans stop synthesizing vitamin C?

4 min read

The inability of humans to produce our own vitamin C is a metabolic error that affects all of us, a genetic quirk we share with other primates like apes and monkeys. This fundamental biological change prompts the question: when did humans stop synthesizing vitamin C, and what happened as a result?

Quick Summary

Human inability to produce vitamin C is due to an inactive GULO gene, a mutation occurring in haplorhini primates around 61 million years ago, creating dietary dependence.

Key Points

  • GULO Gene Inactivation: The loss of vitamin C synthesis was caused by mutations in the GULO gene, which encodes the enzyme L-gulonolactone oxidase, essential for the final step of vitamin C production.

  • Time of Inactivation: This genetic event occurred around 61 million years ago, in the shared ancestor of all haplorhini primates, the suborder that includes monkeys, apes, and humans.

  • Primate Lineage Split: The inability to synthesize vitamin C is characteristic of haplorhini primates, while the strepsirrhini suborder (e.g., lemurs) retained the functional gene.

  • Neutral Mutation Theory: The loss may have been a neutral mutation that was not selected against because the ancestral diet was rich in vitamin C from fresh fruits.

  • Evolutionary Compensation: Some theories suggest that other antioxidants, like uric acid, may have compensated for the loss of endogenous vitamin C production.

  • Scurvy Risk: The most significant consequence is human dependence on dietary vitamin C, which can lead to scurvy if intake is insufficient.

In This Article

The genetic loss of vitamin C synthesis

At the core of the human inability to synthesize vitamin C is the loss of a single, crucial enzyme: L-gulonolactone oxidase (GULO). This enzyme is responsible for catalyzing the final step of vitamin C (or ascorbic acid) production in the body. The genetic code for this enzyme exists in our DNA, but it is now a 'pseudogene'—a non-functional copy of a gene that has accumulated multiple mutations over millions of years. In contrast, the vast majority of other mammals retain a functional GULO gene and can produce their own vitamin C. The permanent inactivation of the GULO gene in humans was caused by a variety of mutations, including insertions, deletions, and point mutations, resulting in premature stop codons that prevent the production of the enzyme.

The primate evolutionary timeline

Scientists have used comparative genomics and 'molecular clock' dating to pinpoint the approximate time when this genetic event occurred. It's a key divergence point in the primate evolutionary tree that separates those who can and cannot make their own vitamin C. The ability to synthesize vitamin C was lost in the ancestors of haplorhini primates, the suborder that includes monkeys, apes, and humans, approximately 61 million years ago (MYA). The other primate suborder, strepsirrhini (which includes lemurs), retained the functional GULO gene and can still produce their own vitamin C. This means that the mutation occurred before the split between Old World and New World monkeys. The last common ancestor of all haplorhine primates already carried this genetic change, passing it down to all subsequent species, including modern humans.

Potential evolutionary advantages and consequences

Why would losing a seemingly vital ability be evolutionarily beneficial? Scientists have proposed several theories:

  • Dietary availability: It is theorized that the GULO gene may have become inactivated when the diet of early primates was rich in fresh, vitamin C-dense fruits and vegetables. Because vitamin C was readily available in their food, the selective pressure to maintain the costly metabolic process of synthesizing it was relaxed. The mutation would not have posed a survival disadvantage and could therefore spread through the population via neutral evolution.
  • Uric acid compensation: Some researchers suggest that higher primates may have benefited from increased levels of uric acid after the loss of GULO function. Uric acid is a potent antioxidant, and it's possible that it took over some of the antioxidant roles previously performed by vitamin C. This might have provided a selective advantage by increasing antioxidant capacity without the metabolic cost of synthesizing vitamin C.
  • Reduced oxidative stress: Another hypothesis posits that the synthesis of vitamin C via the GULO pathway generates hydrogen peroxide as a byproduct, which can induce oxidative stress. The loss of this pathway would have removed a source of oxidative damage, potentially offering a net benefit to early primates.

Despite these potential advantages, the ultimate consequence of this gene loss is our dietary dependence on external sources of vitamin C. This vulnerability was most famously highlighted during long sea voyages in the Age of Sail, when sailors developed scurvy from a lack of fresh produce.

What happened to the GULO gene?

The non-functional GULO gene in humans is a prime example of a 'unitary pseudogene'. Unitary pseudogenes are created by inactivating mutations, such as insertions or deletions (indels), within a once-functional gene. The human GULO pseudogene has been thoroughly sequenced, and comparisons with functional GULO genes in other mammals reveal the extent of the genetic degradation. While humans and other apes have a shared inactivation event, the specific mutations in the GULO pseudogene differ among haplorhini primates, suggesting independent degradation after the initial inactivation.

Feature Functional GULO Gene (e.g., in rats) GULO Pseudogene (in humans)
Function Encodes active L-gulonolactone oxidase enzyme. Non-functional; does not produce active enzyme.
Genetic Integrity Intact coding sequence, typically with 12 exons. Accumulation of disabling mutations like stop codons and deletions.
Vitamin C Synthesis Permits the organism to produce its own vitamin C from glucose. Blocks the final step of the vitamin C synthesis pathway.
Enzyme Activity Catalyzes the conversion of L-gulono-1,4-lactone to vitamin C. No catalytic activity for vitamin C production.
Status in Evolution Retained due to ongoing selective pressure. Lost its function due to a combination of genetic drift and environmental factors.

The legacy of the GULO gene loss

For modern humans, the legacy of this ancient genetic event is our complete reliance on diet for vitamin C. Scurvy, the disease caused by severe vitamin C deficiency, serves as a harsh reminder of this dependence, leading to fatigue, bleeding gums, impaired wound healing, and, if left untreated, death. The historical recurrence of scurvy among human populations with limited access to fresh food illustrates that, while the gene loss may have been neutral in a fruit-rich ancestral environment, it became a significant liability under different dietary conditions. The study of this unique metabolic flaw offers a compelling window into human evolutionary history, highlighting how genetic drift and environmental adaptation can lead to permanent changes in our physiological makeup.

Conclusion

In conclusion, humans and other haplorhini primates lost the ability to synthesize vitamin C due to disabling mutations in the GULO gene approximately 61 million years ago. This shift transformed vitamin C from an endogenously produced molecule into an essential dietary nutrient. The loss is a classic example of evolutionary change where a non-functional gene becomes a 'pseudogene,' though the exact selective pressures driving or permitting this change—whether increased dietary fruit intake, co-optation by other antioxidants, or reduced oxidative stress—are still debated among scientists. Our continued dietary need for vitamin C is a direct result of this deep evolutionary event. It's a reminder of our link to our primate relatives and the profound impact that genetic history has on modern human health.

Explore the genetic basis of vitamin C synthesis

Frequently Asked Questions

The GULO gene encodes the enzyme L-gulonolactone oxidase, which is necessary for the final step of vitamin C synthesis. In humans, this gene became inactive due to accumulated mutations, including deletions and insertions, transforming it into a non-functional pseudogene.

No, the loss of vitamin C synthesis is specific to the haplorhini suborder of primates, which includes monkeys, apes, and humans. The strepsirrhini suborder, which includes lemurs and lorises, still retains a functional GULO gene.

The inactivation of the GULO gene is estimated to have occurred in the ancestor of all haplorhine primates approximately 61 million years ago, before the divergence of Old World and New World monkeys.

Early primates and human ancestors likely obtained sufficient vitamin C from their diets, which were rich in fresh fruits, vegetables, and other plant sources. This constant dietary availability made the internal synthesis of vitamin C redundant and allowed the gene mutation to persist.

Insufficient dietary vitamin C leads to a deficiency disorder called scurvy. Symptoms include fatigue, bleeding gums, bruising, and impaired wound healing. In severe cases, it can be fatal.

One theory suggests the loss might have provided an evolutionary advantage by saving metabolic energy and potentially by allowing a different antioxidant, uric acid, to take on some of vitamin C's roles. The GULO synthesis pathway also produces hydrogen peroxide, so losing it may have reduced cellular oxidative stress.

The loss was not fatal for our ancestors because their diet consistently provided ample vitamin C. As long as they had access to fruit-rich environments, there was no selective pressure to retain the gene, allowing the mutation to become fixed in the population.

References

  1. 1
  2. 2
  3. 3
  4. 4

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.